Not known Details About BRD4 inhibition by ABBV-744 in cancer research studies
These side effects were notably milder as compared to an inhibitor of the two bromodomains. An in depth molecular Assessment also uncovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes. ― Stephen TaylorProbable new ways for your diagnosis and treatment of AML. (A) The identification of Tremendou